Elon Musk Meets BRIDGE UAE Leadership to Explore Future of Media, Technology, and AI, and Receives Invitation to Inaugural BRIDGE Summit 2025
28.9.2025 16:10:00 CEST | Business Wire | Press Release
Elon Musk, CEO of X, SpaceX, Tesla, and Starlink, met with the leadership of the BRIDGE Summit at Tesla’s headquarters in Palo Alto, California, to discuss the future of technology and media and explore collaboration. During the meeting, Musk was invited to participate in the inaugural BRIDGE Summit, the world’s largest debut gathering for media, content, and entertainment, taking place in Abu Dhabi (December 8-10).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250928721191/en/
H.E. Abdulla bin Mohammed bin Butti Al Hamed, Chairman of the UAE Media Council and Chairman of BRIDGE, meets Elon Musk, CEO of X, SpaceX, Tesla, and Starlink, at Tesla Headquarters in Palo Alto, California (Photo: AETOSWire)
The BRIDGE delegation was led by H.E. Abdulla bin Mohammed bin Butti Al Hamed, Chairman of the UAE National Media Office, the UAE Media Council, and BRIDGE. The meeting aligns with BRIDGE’s strategy to build partnerships with technology leaders and global innovation hubs, and broaden avenues of collaboration between media industry and advanced technologies.
The discussion focused on AI, data centres and content integrity as transformation drivers. Musk stressed that innovation will depend on countries’ ability to provide data centres powered by clean and affordable energy, noting the UAE’s strong positioning. H.E. Al Hamed affirmed the UAE provides clean, low-cost energy with large-scale capabilities and global competitiveness, reinforcing its readiness to lead in AI and advanced technologies.
Musk praised UAE’s forward-looking vision under the leadership of His Highness Sheikh Mohamed bin Zayed Al Nahyan and commended the efforts of His Highness Sheikh Tahnoun bin Zayed Al Nahyan and the role of Mohamed bin Zayed University of Artificial Intelligence in consolidating UAE’s standing as an innovation hub.
During a tour of the Optimus robotics lab, the parties discussed balancing innovation with ethical regulatory frameworks. They emphasized the need for a global framework for responsible AI use in content creation, regulation, and distribution.
Cooperation opportunities were reviewed, including UAE’s media and tech ecosystem, potential media and AI innovation collaboration, educational content to engage youth in science and entrepreneurship, and initiatives linking green tech with media narratives.
H.E. Al Hamed said: “The UAE believes that the media is a powerful force capable of reshaping knowledge and building awareness. Collaboration with leading institutions enables the exchange of expertise, accelerates the adoption of innovative solutions, and delivers tangible, sustainable impact.”
The BRIDGE Summit will provide “an exceptional platform for testing bold and unconventional solutions” to help reshape the media industry, rebuild trust, and define a shared future.
Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20250928721191/en/
Contacts
Tasnim Hijazi, +971521607687
thijazi@apcoworldwide.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kinaxis Advances Operational Orchestration Vision with Agentic AI at Kinexions EMEA 202615.9.2026 13:00:00 CEST | Press Release
Kinaxis® Inc. (TSX:KXS), a global leader in AI-powered supply chain planning and orchestration, will bring together some of the world’s most innovative supply chain leaders at Kinexions EMEA 2026 from October 26-28. Building on the operational orchestration vision Kinaxis introduced earlier this year, the conference offers an inside look at how leading organizations are harnessing AI innovation and agentic capabilities to help supply chain leaders make better decisions, coordinate action across the business and drive measurable outcomes. From AI Potential to Operational Impact As organizations continue to invest heavily in AI, many struggle to translate intelligence into action - just 12% of supply chain leaders consider themselves AI leaders, despite widespread deployment of AI capabilities. Kinaxis CEO Razat Gaurav and Executive Vice President, EMEA, Fabienne Cêtre, will open the mainstage with an exploration of the market forces reshaping global supply chains and how operational orc
Cebreo Medical Receives CE Mark for NeuroBuds®, a Discreet In-Ear, Medical-Grade EEG Wearable for Extended Ambulatory Monitoring15.9.2026 13:00:00 CEST | Press Release
Cebreo Medical today announced that its NeuroBuds® device has received CE marking, confirming conformity with applicable EU requirements. Unlike conventional EEG systems that require a technician-applied cap of electrodes, NeuroBuds is designed to be used unassisted by the patient at home, enabling multi-day and multi-night recordings in a patient's daily life environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260914704547/en/ NeuroBuds(TM), EarEEG “With NeuroBuds, we can offer a discreet, unobtrusive solution that enables long-term, unassisted EEG monitoring for weeks, in patients’ own homes. The product has the potential to significantly reduce the cost of long-term EEG monitoring and strengthen treatment decisions compared with conventional brain monitoring.” — Rasmus Madsen, CEO, Cebreo Medical Designed to resemble a hearing aid, NeuroBuds is built to minimize the stigma and burden that typically limit complianc
Compass Pathways Launches ‘Change the Tune in TRD’ in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 202615.9.2026 12:30:00 CEST | Press Release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced the launch of Change the Tune in TRD, a new U.S. HCP disease education initiative, to deepen understanding and increase recognition of TRD. The campaign explores the neurobiology of this distinct form of depression and is designed to help navigate care pathways for patients and providers. Change the Tune in TRD was developed to provide evidence-based education to U.S. HCPs on the longer, more persistent episodes associated with TRD, alongside cognitive and emotional patterns, including getting stuck in negative or repetitive ways of thinking, difficulty shifting perspective or navigating emotions, and feeling disconnected from pleasure or motivation1-8. While TRD originates as MDD, its burden and resistance to standard treatments distinguish it as a more complex condition. Compared to MDD, TRD patients experience almost 3x long
NIQ Launches Digital Purchase GeoAudiences Across Europe15.9.2026 12:00:00 CEST | Press Release
NIQ (NYSE: NIQ), a leading consumer intelligence company, today announced the launch of Digital Purchase GeoAudiences across five European markets. The new solution extends NIQ’s geographic audience capabilities into digital-first categories including travel, automotive, technology, telecommunications and financial services. The launch expands NIQ’s GeoPurchase offering, which currently provides syndicated audiences across 13 international markets. Digital Purchase GeoAudiences address growing demand from advertisers for purchase-informed audience intelligence across a broader range of digital-first industries and shopping environments. By combining NIQ’s digital commerce intelligence with its GeoPurchase framework, the solution helps advertisers identify geographic areas showing stronger digital shopping activity. Marketers can use these signals to inform where they plan and prioritize media investment. “Marketers shouldn’t have to guess where demand is coming from before they invest,
QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies for Central and Peripheral Nervous System Diseases15.9.2026 12:00:00 CEST | Press Release
QurCan Therapeutics (“QurCan”), a biotechnology company pioneering non-viral, polymer-lipid nanoparticle (PLNP) delivery of genetic medicines through its proprietary TERP™ (Target-Engineered Responsive Polymer) platform, today announced an exclusive research and collaboration agreement with Eli Lilly and Company (“Lilly”) for the treatment of diseases of the central nervous system (CNS) and peripheral nervous system (PNS). Lilly and QurCan will collaborate on multiple research programs focused on the development of PLNP-enabled genetic medicine therapeutics for CNS and PNS delivery. Through this collaboration, QurCan will be responsible for optimizing genetic medicine therapeutics using its TERP platform, and Lilly will be responsible for further research, clinical development, and commercialization of the selected programs. “This collaboration with Lilly represents a validation of our PLNP technology platform and its potential to address some of the most challenging delivery problems
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom